Arcus Biosciences, Inc. (RCUS)
21.47
+0.01
(+0.05%)
USD |
NYSE |
Mar 26, 14:04
Arcus Biosciences Free Cash Flow : -484.00M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.456B |
| Eli Lilly & Co. | 5.964B |
| Merck & Co., Inc. | 12.36B |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -120.00M |
| Cash from Investing (Quarterly) | -182.00M |
| Cash from Financing (Quarterly) | 286.00M |
| Free Cash Flow Per Share (Quarterly) | -1.021 |
| Free Cash Flow to Equity (Quarterly) | -208.00M |
| Free Cash Flow to Firm (Quarterly) | -119.00M |
| Free Cash Flow Yield | -20.98% |